cosinuss° joins DiME’s DATAcc project “Building the Business Case for Digital Endpoints” to revolutionize clinical trials
Posted:
DATAcc by DiMe launches its new project, “Building the Business Case for Digital Endpoints,” aimed at advancing the adoption of digital health measures in clinical trials. Read the full article here.
Antimicrobial resistance could claim almost two million lives a year by 2050. Now, researchers believe they could use #AI to predict which bugs will become resistant so that we can better prepare.
Read the full article here.
Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy, a company spokesperson confirmed to STAT. New data show early hints of the medicine improving patient…
Attendees
Sponsors and Exhibitors
AI In Healthcare: A Virtual Course
Contact us